A Seamless Phase I/II Design With Randomization for Biomarker‐Guided Oncology Trials

Emily C. Zabor, Sneha Govande, Wen Wee Ma, Brian P. Hobbs
Pharmaceutical Statistics · Wiley · 2026-09-21 · DOI: 10.1002/pst.70124

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles